Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Depreciation & Amortization
Tibet Rhodiola Pharmaceutical Holding Co
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Depreciation & Amortization
-¥26m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Depreciation & Amortization
-¥1.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Depreciation & Amortization
-¥139.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
Huadong Medicine Co Ltd
SZSE:000963
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Depreciation & Amortization?
Depreciation & Amortization
-26m
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Depreciation & Amortization amounts to -26m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-44%
Over the last year, the Depreciation & Amortization growth was 14%. The average annual Depreciation & Amortization growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been -60% over the past three years , -44% over the past five years .